Work

Kinome reprogramming response to MEK inhibition: A window-of-opportunity trial in triple-negative breast cancer (TNBC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.512

Authors: Gary L. Johnson, Keith D. Amos, James S Duncan, Marty Whittle, Jon Zawistowki, Dan Goulet, Xiaping He, Jeanne Noe, Charles M. Perou, Shelton Earp, Lisa A. Carey

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601359557

Cites:

Cited by: 7

Related to: 10